Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain: An 18-Month Study
Authors:
- Perry G. FinePFPerry G. Fine
- John MessinaJMJohn Messina
- Fang XieFXFang Xie
- James RathmellJRJames Rathmell
- 1 November 2010
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 40 (5) , 747-760
Abstract
No abstract availableKeywords
Funding Information
- Cephalon, Inc.
- Cephalon, Inc
This publication has 21 references indexed in Scilit:
- Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer PainThe Journal of Pain, 2009
- Research Gaps on Use of Opioids for Chronic Noncancer Pain: Findings From a Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice GuidelineThe Journal of Pain, 2009
- Fentanyl buccal tabletDrugs of Today, 2008
- Long-term Use of Controlled-release Oxycodone for Noncancer Pain: Results of a 3-year Registry StudyThe Clinical Journal of Pain, 2007
- A Randomized, Placebo-controlled Study of Fentanyl Buccal Tablet for Breakthrough Pain in Opioid-treated Patients With CancerThe Clinical Journal of Pain, 2006
- Prevalence and Characteristics of Breakthrough Pain in Opioid-Treated Patients With Chronic Noncancer PainThe Journal of Pain, 2006
- Opioid Prescriptions by U.S. Primary Care Physicians From 1992 to 2001The Journal of Pain, 2006
- Fentanyl Effervescent Buccal TabletsAmerican Journal of Drug Delivery, 2006
- Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000Pain, 2004
- Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospicePalliative Medicine, 2001